PTC Therapeutics Inc
DUS:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PTC Therapeutics Inc
DUS:BH3
|
US |
|
M
|
Microbot Medical Inc
F:CY9D
|
US |
|
PSP Swiss Property AG
SIX:PSPN
|
CH |
|
Azerion Group NV
F:9Q9
|
NL |
|
Japan Real Estate Investment Corp
OTC:JREIF
|
JP |
|
Vivoryon Therapeutics NV
F:05Y
|
DE |
|
A
|
Ameriprise Financial Inc
SWB:A4S
|
US |
|
L
|
Luk Fook Holdings (International) Ltd
XMUN:LUY1
|
HK |
|
New Oriental Education & Technology Group Inc
F:N1UA
|
CN |
|
Societe Generale SA
MIL:GLE
|
FR |
|
T
|
Toyota Industries Corp
XMUN:TAH
|
JP |
|
M
|
MTU Aero Engines AG
XBER:MTX
|
DE |
|
S
|
Schlumberger NV
LSE:0SCL
|
US |
|
T
|
Trane Technologies PLC
SWB:2IS
|
IE |
|
Z
|
Zions Bancorporation NA
NASDAQ:ZION
|
US |
|
Haier Smart Home Co Ltd
F:HAI0
|
CN |
|
Barrick Mining Corp
SIX:B
|
CA |
|
S
|
Scentre Group
SWB:59S
|
AU |
|
C
|
Cigna Group
SWB:CGN
|
US |
Bankruptcy Probability
PTC Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PTC Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
6.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
367.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PTC Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PTC Therapeutics Inc has total debt of 2B USD. This includes both short-term (0 USD) and long-term (2B USD) debt.
You can find a full breakdown on its Balance Sheet.
